Success Stories: EB-1A Approved for a Postdoctoral Research Associate in North Carolina in the Field of Molecular Pharmaceutics
Client’s Testimonial:
Thank you. I really appreciate your help in the process.
We Received EB1-A (Alien of Extraordinary Ability) Approval on October 15th, 2014 for a Postdoctoral Research Associate inNorth Carolina in the Field of Molecular Pharmaceutics (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: October 15th, 2014
Processing Time: 5 Months, 29 Days
In this case, the client that we had the pleasure of working with was a Postdoctoral Research Associate from China in the field of Molecular Pharmaceutics. His specialized research has focused on the development of nanomaterials for tumor cell-targeted delivery of anti-cancer therapeutics. His work had resulted in at least 24 peer-reviewed scientific articles, 2 book chapter contributions, and 14 presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 176 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 37 manuscript reviews for at least 16 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from a recommender, “[Client]’s molecular pharmaceutics research is an example of the latest investigations and discoveries in nanomedicine being pioneered in the United States, discoveries that are leading the way in the creation of new nano-carriers and the development of molecular pharmaceutics. In addition, as components of a transformative evolution in medicine, [client]’s research achievements are fertile ground for other scientists to find inspiration and develop their own projects based on his discoveries.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Molecular Pharmaceutics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 5 months and 29 days.